Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CD5 chimeric antigen receptor for adoptive T cell therapy

CD5 chimeric antigen receptor for adoptive T cell therapy

US Patent 10786549 · Granted Sep 29, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Reprogramming CD4 t cells into cytotoxic CD8 cells by forced expression of CD8ab2025
Oncolytic virotherapy with helper-dependent adenoviral-based vectors expressing 2024
Histone deacetylase (HDAC) inhibitor up-regulates car expression and targeted an2023
Compositions and methods for the treatment of HER2-expressing solid tumors2022
Methods for inducing selective apoptosis2021
Oncolytic virotherapy and immunotherapy2020
Histone deacetylase (HDAC) inhibitor up-regulates car expression and targeted an2019
Immunotherapy of cancer using genetically engineered GD2-specific T cells2016
Methods for inducing selective apoptosis2016
Methods for inducing selective apoptosis2015
Gene therapy expression of GHRH for increasing RBC count in subjects2012
Treating anemia in subjects by administration of plasmids encoding growth hormon2007